Novo Nordisk stock surges 7% after Ozempic maker’s latest weight loss drug shows promise
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger.
Novo Nordisk next-gen shot shows 22% weight loss in early results
One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their weight in 36 weeks, according to early-stage trial results on Friday, boosting the drugmaker's shares.
The Health Risks and Benefits of Weight-Loss Drugs
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight. In report published in Nature Medicine,
Novo Rises After Experimental Shot Delivers 22% Weight Loss
Novo Nordisk A/S rose the most in a month after an experimental shot delivered as much as 22% weight loss in an early-stage trial, boosting investors’ hopes for the drugmaker’s pipeline.
Novo Nordisk Stock Surges On Weight Loss Drug Data and Analysts Say It's Still a Buy
Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight loss drug. Here's what you need to know.
Novo Nordisk Shares Surge on New Obesity Drug Results
Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their bodyweight in a clinical trial.
Novo Nordisk reports 22% weight loss in early subcutaneous amycretin trial
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying people with obesity or overweight treated with the drug achieved a 22% weight loss after 36 weeks.
Novo Nordisk Stock Soars on New Weight-Loss Drug Results
Novo Nordisk scored a much-needed win on Friday, with early-stage data on a new weight-loss drug that suggested it could work better than the obesity blockbusters already on the market. Novo American depositary receipt was down 38% in the six months prior to Friday’s announcement,
Novo Nordisk shares pop 9% on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
How Much Weight Can I Safely Lose in Just a Week?
Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...
E!2h
Oprah Winfrey Shares What She Learned About “Thin People” After Experience With Weight-Loss Drug
Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...
What you should know about carbonated water and weight loss
Carbonated drinks known as sparkling, fizzy, seltzer and soda waters are thought to impact the waistline. A new study weighs ...
Carbonated Water Could Boost Weight Loss, New Study Suggests: Here's What To Know, According To A Dietitian
Don't expect to shed pounds solely due to your choice of beverage. The benefits of drinking carbonated water for weight loss ...
Can Lexapro Cause Weight Loss? What to Know
If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...
Carbonated Water 'May Promote Weight Loss,' According to New Study
The body absorbs the carbon in a way that “may support weight loss,” according to a new study, but carbonated drinks are not ...
What to know about sparkling water and weight loss, according to new study
To break down the study's findings, ABC News chief medical correspondent Dr. Tara Narula joined "Good Morning America" on Wednesday and explained that for those looking to carbonated water to support ...
The Express Tribune6h
Gemma Collins reveals weight loss transformation using Mounjaro injections
Gemma Collins reveals weight loss with Mounjaro injections, showcasing a new look and expressing newfound confidence.